Methylperon. (Buronil "Ferrosan") . A new butyrophenone neuroleptic
Lingjaerde, O.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 92(3): 192-193
1972
ISSN/ISBN: 0029-2001 PMID: 5016100 Document Number: 57172
Document emailed within 1 workday
Related Documents
Shapovalova, V.O.; Mykhaĭlov, V.S.; Shapovalov, V.V. 1999: The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptic--a butyrophenone derivative--in experiments on mice Fiziolohichnyi Zhurnal 45(3): 114-117Falck-Larsen, J. 1974: Drug information. new drugs. Ritodrine (Utopar, Philips-Duphar/Ferrosan) Ugeskrift for Laeger 136(49): 2761
2009: Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents Prescrire international 18(104): 251
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Gao, X.-y. 2012: Determination of four n-butyrophenone compounds contained in rhubarb using RP-HPLC Zhongguo Zhong Yao Za Zhi 37(17): 2594-2596
Simpson, G.M.; Varga, V. 1974: An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia Current Therapeutic Research 16(5): 477-482
Brooks, S.C.; D'Angelo, L.; Chalmeta, A.; Ahern, G.; Judson, J.H. 1983: An unusual schizophrenic illness responsive to pyridoxine HCl (B6) subsequent to phenothiazine and butyrophenone toxicities Biological Psychiatry 18(11): 1321-1328
Krzek, J.; Maślanka, A. 2000: Densitometric determination of impurities in pharmaceuticals. Part VI. Determination of 4,4-bis[4-(p-chlorophenyl)- 4-hydroxypiperidino]butyrophenone in haloperidol Acta Poloniae Pharmaceutica 57(1): 23-26
Borzecki, Z.; Kleinrok, Z.; Mlynarczyk-Góral, W. 1970: The influence of butyrophenone derivatives on the level of 5-hydroxytryptamine in the normal rat brain and in the rat brain after nialamide pretreatment Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 25: 481-485
Kostowski, W.; Płaznik, A. 1984: Neuroleptic drugs Wiadomosci Lekarskie 37(3): 233-236
Suchanová, L. 1985: Malignant neuroleptic syndrome Ceskoslovenska Psychiatrie 81(2): 91-95
Gunne, L.M. 1974: Neuroleptic medication questioned Lakartidningen 71(12): 1161-1162
Johannessen, J.O.; Bergrem, H. 1989: Neuroleptic malignant syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 109(6): 696-697
Vallance, H.; McConachie, I. 1993: Neuroleptic malignant syndrome and ECT British Journal of Hospital Medicine 49(1): 50
Retamal, P. 1990: Neuroleptic malignant syndrome Revista Medica de Chile 118(6): 679-685
Fleischhacker, W.W.; Miller, C.H.; Bergmann, K.J. 1989: Neuroleptic-induced akathisia Der Nervenarzt 60(12): 719-723
Till, E.; Vucković, S.; Lisulov, R.; Nedić, A. 1989: The neuroleptic malignant syndrome Medicinski Pregled 42(11-12): 419-423
Müller, T.; Becker, T.; Fritze, J. 1989: Neuroleptic malignant syndrome Deutsche Medizinische Wochenschrift 114(11): 442-443
Eikmeier, G. 1987: Priapism in neuroleptic therapy Der Nervenarzt 58(12): 771-772